All dollar amounts expressed are in U.S. dollars. TORONTO--(BUSINESS WIRE)-- Largo Inc. (LGO), a vanadium producer, is pleased to announce the establishment of an at-the-market equity offering program ...

TORONTO--(BUSINESS WIRE)-- Cybin Inc. (CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to advancing mental healthcare by developing new and innovative ...

All dollar amounts expressed are in U.S. dollars. Largo Inc. ("Largo" or the "Company") (TSX: LGO) (NASDAQ: LGO), a vanadium producer, is pleased to announce the establishment of an at-the-market ...

Fuelcell Energy ( (FCEL)) has shared an announcement. On December 30, 2025, FuelCell Energy amended its Open Market Sale Agreement with a syndicate of sales agents including Jefferies, B. Riley ...

Strategy keeps buying Bitcoin during downturns by tapping equity markets and reserves, turning dilution and financing costs into a repeatable Bitcoin accumulation strategy. Strategy funds its dip ...

ATLANTA--(BUSINESS WIRE)--Volato Group, Inc. (the “Company” or “Volato”) (NYSE American: SOAR), today announced that it has elected to pause its at-the-market equity offering program (“ATM”) through ...

Forbes contributors publish independent expert analyses and insights. I consult on marketing strategy, content creation, and messaging. The market is pricing Strategy (NASDAQ: MSTR), formerly ...

Michael Saylor’s Strategy bought 1,286 BTC for $116 million, raising its Bitcoin holdings to 673,783 BTC and U.S. dollar reserves to $2.25 billion. Michael Saylor’s Strategy, the Tysons Corner, ...

After market close on Tuesday, FuelCell said in a filing it entered into an amended sales agreement to increase the amount of shares that may be sold under its sales agreement to $200 million.

On this blog, we have commented quite a number of times regarding a number of trends affecting our capital markets—many of which have been a factor since the early 2000s and which have become more ...

Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of patient-, physician-, caregiver- and societal-friendly medicinal ...